New Chemical Entity Exclusivity Determinations for Certain Fixed-Combination Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 16, 2014
May 14, 2020
d74952b7-1888-42ca-8591-fe4e8262275d
Related Documents
Sunscreen Innovation Act: Withdrawal of a 586A Request or Pending Request Guidance for Industry
Guidance DocumentOctober 11, 2016Center for Drug Evaluation and Research
Naming of Drug Products Containing Salt Drug Substances
Guidance DocumentJune 17, 2015Center for Drug Evaluation and Research
SUPAC: Manufacturing Equipment Addendum
Guidance DocumentDecember 2, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.